We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





Technopath Showcases Third Party Quality Controls and Quality Control Software Solutions at AACC 2021

By LabMedica International staff writers
Posted on 28 Sep 2021
Print article
Image: Multichem ID-Covid 19 Quality Controls (Photo courtesy of Technopath Clinical Diagnostics)
Image: Multichem ID-Covid 19 Quality Controls (Photo courtesy of Technopath Clinical Diagnostics)

Technopath Clinical Diagnostics (Tipperary, Ireland) showcased its third party quality controls and quality control software solutions at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo held at the Georgia World Congress Center in Atlanta, September 26-30.

The event allowed more than 400 exhibiting companies to showcase the latest product innovations, emerging technologies, and research, and provided the opportunity to browse exhibitors in person for the solutions to lab related needs.

Technopath is one of the largest manufacturers of liquid-ready Quality Control globally in compliance with the highest quality standards. At AACC 2021, the company highlighted Multichem, its class leading third party consolidated Quality Control product range which incorporates a greater number of analytes to enable extensive test menu and control product consolidation. The Multichem IA+ control, for example, allows consolidation of the company’s competitors’ immunoassay, cardiac marker, tumor marker and specialty immunoassay controls into one control. This consolidation allows laboratories to simplify their inventory, reduce costs and improve efficiencies.

For instance, Multichem ID-COVID19 controls are the essential independent quality controls designed to test the precision of assays for antibodies IgG and IgM to SARS-CoV-2, to allow clinical laboratories to release patient results with confidence. The company also exhibited its flagship chemistry product, Multichem S Plus (S for Serum) which consolidates over 100 analytes in to a single product. Also on display was Technopath's leading diabetes product, Multichem A1c, which is a third party QC for hemoglobin A1c. Other products displayed at the event included flagship immunoassay product is Multichem IA Plus which consolidates over 90 analytes in to a single product and can replace up to four competitor products in the lab; and its leading urine chemistry control is Multichem U which provides a single product to cover the majority of standard urine chemistry assays, including Microalbumin, which some competitors provide a separate QC product for.

Alomgside its Multichem quality control product range, Technopath also demonstrated its IAMQC Software which provides laboratory managers and technologists with a range of QC software tools to analyze their QC results in real-time. IAMQC Software tools allow users to automate, centralize, standardize and improve QC processes in a laboratory setting. A combination of modules satisfies the varying levels of QC requirements in individual laboratories and are easily tailored to meet different QC management expectations.

Related Links:
Technopath Clinical Diagnostics

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
ADLM

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.